The largest database of trusted experimental protocols

8 protocols using pgl3 luc reporter vector

1

Luciferase Assay for LIMS1 3'UTR

Check if the same lab product or an alternative is used in the 5 most similar protocols
In this study, we constructed a plasmid that contained the amplified 3′UTR sequence of LIMS1 from genomic DNA, using the specified primers listed in Table S1. Additionally, we also included LIMS1 mutant variants in the plasmid construct. The amplified 3′UTR sequence of LIMS1, along with the mutant variants, was successfully inserted into the pGL3‐LUC reporter vector obtained from Promega, located in Madison, USA. This vector is a widely used tool for luciferase reporter assays, allowing the measurement of gene expression regulatory elements. In order to investigate the impact of RBMS3 binding sites on LIMS1, HCT116 cells were seeded into 24‐well plates. Subsequently, the cells were co‐transfected with the pGL3‐LUC reporter vector containing the 3′UTR sequences of LIMS1 (with wild‐type and mutant variants) and the PRL‐TK Renilla luciferase reporter vector, both obtained from Promega. The co‐transfection was achieved using Lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA).To quantify the activities of Firefly and Renilla luciferase reporters, a Promega GloMax®20/20 Luminometer E5311 was employed. To ensure statistical accuracy and reliability, the quantification process was repeated three times.
+ Open protocol
+ Expand
2

Transcriptional Regulation Analysis via Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA fragments were amplified by PCR of human genomic DNA. The primer sequences are shown in Supplementary Table 1. All DNA fragments were inserted into the pGL3-LUC reporter vector (Promega, Madison, WI, USA). Mutants were generated using overlap-extension PCR. The SuperFect reagent (Qiagen, Hilden, Germany) was used to co-transfect 293T cells at a density of 2 × 105 with the pcDNA3 vectors (0, 10, 50, or 100 ng) with or without A/E cDNA and plated in 24-well plates. The pRL-TK renilla luciferase reporter vector (Promega, Madison, WI, USA) was used as a control. According to the manufacturer’s instructions, cells harvested 48 h after transfection were analyzed using the Dual-Luciferase® Reporter assay (Promega, Madison, WI, USA).
+ Open protocol
+ Expand
3

Luciferase Assay for miR-211 Targeting

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 3′-UTR of the target gene, which contains the binding sites of miR-211, was amplified by PCR from genomic DNA. The primers are presented in Supplementary Table 2. The sequence was inserted into the pGL3-LUC reporter vector (Promega). Briefly, 293TN cells were seeded into 96-well plates at a density of 2 × 104 cells per well. Twenty-four hours later, the cells were cotransfected with pGL3-LUC reporter vectors, pRL-TK Renilla luciferase reporter vectors (Promega) and miR-211 mimics or NC. Transfection was performed using Lipofectamine 2000 (Invitrogen). Forty-eight hours posttransfection, Firefly and Renilla luciferase were detected using Promega GloMax® 20/20 Luminometer E5311. All assays were replicated three times.
+ Open protocol
+ Expand
4

Luciferase Assay for AML1-ETO

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA fragments were amplified by PCR from human genomic DNA. Primer sequences are shown in Supplementary Table 1. All fragments were then inserted in the pGL3-LUC reporter vector (Promega, Madison, WI, USA, E1751). The mutant was generated by the overlap-extension PCR method. HEK293T cells were plated in 24-well plates (each well consists of 2 × 105 cells) and were transiently cotransfected by the SuperFect reagent (QIAGEN, Valencia, CA, USA, 301305) with 10, 50, or 100 ng of the pcDNA3.0 vectors with or without the AML1-ETO cDNAs and 400 ng of the LUC reporter constructs as described above. A cotransfected pRL-TK renilla luciferase reporter vector (Promega, Madison, WI, USA, VQP0126) was simultaneously used as an internal control. All cells were harvested 48 h after the transfection and then assayed by the dual luciferase assay (Promega, Madison, WI, USA, E1910) according to the instructions of the manufacturer.
+ Open protocol
+ Expand
5

Regulation of KAT6B Promoter Activity by EZH2

Check if the same lab product or an alternative is used in the 5 most similar protocols
KAT6B promoter fragments were amplified from human genomic DNA by PCR. Primer sequences are shown in Additional file 1: Table S1. All fragments were inserted into the pGL3-LUC reporter vector (Promega). Corresponding mutants were generated using the Site-directed Mutagenesis Kit (Sangon Biotech (Shanghai) Co., Ltd., Shanghai, China) according to the manufacturer’s instructions. All constructs were verified by DNA sequencing. HEK293T cells (2 × 105) were seeded in a 24-well plate for 12 h, and 100 ng of the blank pcDNA3 vector or the pcDNA3 vector containing the EZH2 cDNA and the 400 ng LUC reporter vector were co-transfected into the cells for 48 h. Co-transfection with the pRL-TK Renilla Luciferase Reporter Vector (Promega) was used as a control. After transfection, cells were harvested and analyzed using Dual Luciferase Assay (Promega) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
6

Transcriptional Regulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA fragments were synthesized by Sangon Biotech (Shanghai, China) and inserted into the pGL3-LUC reporter vector (Promega). Approximately 2 × 105 HEK293T cells were plated in 24-well plates and transiently cotransfected with 10, 50, or 100 ng of the pcDNA3.0 vector with or without HA-tagged RUNX1/RUNX1T1 cDNA12 (link) and 400 ng of the LUC reporter construct. Cotransfection with 10 ng of the pRL-TK Renilla luciferase reporter vector (Promega) was used as an internal control. Lipofectamine™ 2000 Transfection Reagent (Invitrogen) was used for transfection. Cells were harvested 48 h after transfection and assayed using the dual-luciferase assay (Promega) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
7

Validation of miR-34a Binding to OAZ2 3'UTR

Check if the same lab product or an alternative is used in the 5 most similar protocols
The genomic fragments harboring the putative miR-34a-binding sites in human OAZ2 3′UTR were subcloned into the pGL3-Luc reporter vector (Promega, Beijing, China) using Infusion 2.0 Dry-Down PCR cloning kit (Clontech, Shanghai, China). Promoter activity was further validated by mutation of the putative miR-34a-binding site on the OAZ2 3′UTR by replacing ACAC with CACA using the QuikChange II Site-Directed Mutagenesis Kit (Agilent, Santa Clara, CA, USA). For reporter assay, 0.5 μg of pGL3-OAZ2 WT or pGL3-OAZ2 Mu, along with 0.05 μg of pRL-SV40 plasmid and miR-34a mimic, was cotransfected into HeLa cells using FuGENE®6 (Promega). 48 h later, cells were harvested and subjected to luciferase activity measurements using the Promega Dual-Luciferase® Reporter Assay System.
+ Open protocol
+ Expand
8

SETDB2 Promoter Regulation by AML1-ETO

Check if the same lab product or an alternative is used in the 5 most similar protocols
SETDB2 promoter fragments were amplified from human genomic DNA by PCR. Primer sequences are shown in Supplementary Table 1. All fragments were inserted into the pGL3-LUC reporter vector (Promega). Corresponding mutants were generated using the Site-directed Mutagenesis Kit (Sangon Biotech (Shanghai) Co., Ltd., Shanghai, China) according to the manufacturer’s instructions. All constructs were verified by DNA sequencing. 2×105 HEK293T cells were seeded in a 24-well plate for 12 hrs, and 100 ng of the blank pcDNA3 vector or the pcDNA3 vector containing the AML1-ETO cDNA and the 400 ng LUC reporter vector were co-transfected into the cells for 48 hrs. Co-transfection with the pRL-TK Renilla Luciferase Reporter Vector (Promega) was used as a control. After transfection, cells were harvested and analyzed using Dual Luciferase Assay (Promega) according to the manufacturer’s instructions. Luciferase activity was measured on SpectraMax® L (Molecular Devices, Sunnyvill, CA, USA) and analyzed with SoftMax® Pro (Molecular Devices).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!